Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial session on understanding the Current Cancer Scenario in India. The landscape of cancer care in India is rapidly evolving, with a growing emphasis on personalized medicine. The integration of genomic testing has become increasingly important, moving beyond a one-size-fits-all approach to diagnosis and treatment. Recent advancements in technology and a better understanding of cancer biology are enabling healthcare providers to identify specific genetic mutations that drive tumor growth, leading to more targeted and effective therapies.
In a country as diverse as India, with a unique genetic makeup across its population, the importance of genomic testing is paramount. It allows for the identification of hereditary cancer syndromes, a more accurate prognosis, and the selection of therapies that are most likely to work for an individual patient. This is particularly relevant as India grapples with a rising cancer burden, where traditional treatments may not always be the most effective. Genomic testing, therefore, provides a roadmap for clinicians to navigate the complexities of cancer, offering a new level of precision and hope for better patient outcomes.
Therefore, get a deep understanding of the current cancer scenario in India and the transformative role of genomic testing and advanced diagnostics. Listen to this insightful discussion by Dr. Poonam Patil, grab the shared knowledge on the latest advancements in diagnosis and treatment, and follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
A Win for Molecularly Guided Therapy for Cancer of Unknown Primary
2.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
3.
In early dementia, SSRIs enhance cognition and major depression.
4.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
5.
Patients face high out-of-pocket costs after incident cancer diagnosis
1.
Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy
2.
Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates
3.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
4.
Interpreting Iron Studies: What Your Blood Results Really Mean
5.
Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation